Cargando…

A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors

AIMS: Clopidogrel and angiotensin converting enzyme (ACE) inhibitors are commonly co-prescribed drugs. Clopidogrel inhibits carboxylesterase 1 (CES1), the enzyme responsible for converting prodrug ACE inhibitors (such as ramipril and perindopril) to their active metabolites. The clinical implication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cressman, Alex M, Macdonald, Erin M, Fernandes, Kimberly A, Gomes, Tara, Paterson, J Michael, Mamdani, Muhammad M, Juurlink, David N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Pharmacoepidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594702/ https://www.ncbi.nlm.nih.gov/pubmed/25980448 http://dx.doi.org/10.1111/bcp.12682

Ejemplares similares

Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
por: Mamdani, Muhammad, et al.
Publicado: (2019)

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
por: Goh, Kah L, et al.
Publicado: (2015)

Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study
por: Fralick, Michael, et al.
Publicado: (2014)

Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
por: Mackenzie, Isla S., et al.
Publicado: (2016)

‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
por: Murphy, Michael J, et al.
Publicado: (2008)

Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011)

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes
por: Mackenzie, Isla S, et al.
Publicado: (2012)

Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study
por: Cressman, Alex M., et al.
Publicado: (2015)

Comparison of Antihypertensive Drug Classes for Dementia Prevention
por: Walker, Venexia M., et al.
Publicado: (2020)

Evaluating beneficial drug effects in a non‐interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data
por: Wallerstedt, Susanna M., et al.
Publicado: (2017)

Validation of suicide and self-harm records in the Clinical Practice Research Datalink
por: Thomas, Kyla H, et al.
Publicado: (2013)

Prevalence, nature and potential preventability of adverse drug events – a population-based medical record study of 4970 adults
por: Hakkarainen, Katja M, et al.
Publicado: (2014)

Patterns of antiplatelet drug use after a first myocardial infarction during a 10‐year period
por: Yasmina, Alfi, et al.
Publicado: (2016)

Prenatal Opioid Analgesics and the Risk of Adverse Birth Outcomes
por: Brogly, Susan B., et al.
Publicado: (2021)

EUROmediCAT signal detection: an evaluation of selected congenital anomaly‐medication associations
por: Given, Joanne E., et al.
Publicado: (2016)

Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study
por: Zipursky, Jonathan, et al.
Publicado: (2014)

The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort
por: Douglas, Ian J, et al.
Publicado: (2015)

A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC
por: Blin, Patrick, et al.
Publicado: (2015)

Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug‐induced liver injury case–control study in Italy
por: Donati, Monia, et al.
Publicado: (2016)

Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self‐controlled study designs
por: Root, Adrian A., et al.
Publicado: (2016)

Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study
por: Chan, Sze Ling, et al.
Publicado: (2016)

Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study
por: Glamočlija, Una, et al.
Publicado: (2018)

Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations
por: Alping, Peter, et al.
Publicado: (2019)

Evaluation of Medication-mediated Effects in Pharmacoepidemiology
por: Tchetgen Tchetgen, Eric J., et al.
Publicado: (2017)

A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU
por: Weatherall, Mary, et al.
Publicado: (2017)

Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research
por: Pang, Menglan, et al.
Publicado: (2016)

A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients
por: Nateghi, Saeed, et al.
Publicado: (2022)

Causal Effect of Chronic Pain on Mortality Through Opioid Prescriptions: Application of the Front-Door Formula
por: Inoue, Kosuke, et al.
Publicado: (2022)

Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023)

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
por: Zureik, Mahmoud, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Lack of association between proton pump inhibitor use and brain aging: a cross-sectional study
por: Ahn, Nayeon, et al.
Publicado: (2021)

High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study
por: Spooner, Luke, et al.
Publicado: (2016)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l9i4112ljs2hmdhegjbcrhr893